Back to Search Start Over

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

Authors :
Barbour, Sean J.
Coppo, Rosanna
Zhang, Hong
Liu, Zhi-Hong
Suzuki, Yusuke
Matsuzaki, Keiichi
Katafuchi, Ritsuko
Er, Lee
Espino-Hernandez, Gabriela
Kim, S. Joseph
Reich, Heather N.
Feehally, John
Cattran, Daniel C.
Russo, M. L.
Troyanov, S.
Cook, H. T.
Roberts, I.
Tesar, V.
Maixnerova, D.
Lundberg, S.
Gesualdo, L.
Emma, F.
Fuiano, L.
Beltrame, G.
Rollino, C.
Amore, A.
Camilla, R.
Peruzzi, L.
Praga, M.
Feriozzi, S.
Polci, R.
Segoloni, G.
Colla, L.
Pani, A.
Piras, D.
Angioi, A.
Cancarini, G.
Ravera, S.
Durlik, M.
Moggia, E.
Ballarin, J.
Di Giulio, S.
Pugliese, F.
Serriello, I.
Caliskan, Y.
Sever, M.
Kilicaslan, I.
Locatelli, F.
Del Vecchio, L.
Wetzels, J. F. M.
Peters, H.
Berg, U.
Carvalho, F.
da Costa Ferreira, A. C.
Maggio, M.
Wiecek, A.
Ots-Rosenberg, M.
Magistroni, R.
Topaloglu, R.
Bilginer, Y.
D'Amico, M.
Stangou, M.
Giacchino, F.
Goumenos, D.
Kalliakmani, P.
Gerolymos, M.
Galesic, K.
Geddes, C.
Siamopoulos, K.
Balafa, O.
Galliani, M.
Stratta, P.
Quaglia, M.
Bergia, R.
Cravero, R.
Salvadori, M.
Cirami, L.
Fellström, Bengt
Smerud, Hilde Kloster
Ferrario, F.
Stellato, T.
Egido, J.
Martin, C.
Floege, J.
Eitner, F.
Lupo, A.
Bernich, P.
Mene, R.
Morosetti, M.
van Kooten, C.
Rabelink, T.
Reinders, M. E. J.
Boria Grinyo, J. M.
Cusinato, S.
Benozzi, L.
Savoldi, S.
Licata, C.
Mizerska-Wasiak, M.
Martina, G.
Messuerotti, A.
Dal Canton, A.
Esposito, C.
Migotto, C.
Triolo, G.
Mariano, F.
Pozzi, C.
Boero, R.
Bellur, S.
Mazzucco, G.
Giannakakis, C.
Honsova, E.
Sundelin, B.
Di Palma, A. M.
Gutierrez, E.
Asunis, A. M.
Barratt, J.
Tardanico, R.
Perkowska-Ptasinska, A.
Arce Terroba, J.
Fortunato, M.
Pantzaki, A.
Ozluk, Y.
Steenbergen, E.
Soderberg, M.
Riispere, Z.
Furci, L.
Orhan, D.
Kipgen, D.
Casartelli, D.
Ljubanovic, D. Galesic
Gakiopoulou, H.
Bertoni, E.
Cannata Ortiz, P.
Karkoszka, H.
Groene, H. J.
Stoppacciaro, A.
Bajema, I.
Bruijn, J.
Fulladosa Oliveras, X.
Maldyk, J.
Loachim, E.
Bavbek, N.
Cook, T.
Alpers, C.
Berthoux, F.
Bonsib, S.
D'Agati, V
D'Amico, G.
Emancipator, S.
Emmal, F.
Fervenza, F.
Florquin, S.
Fogo, A.
Groene, H.
Haas, M.
Hill, P.
Hogg, R.
Hsu, S.
Hunley, T.
Hladunewich, M.
Jennette, C.
Joh, K.
Julian, B.
Kawamura, T.
Lai, F.
Leung, C.
Li, L.
Li, P.
Liu, Z.
Massat, A.
Mackinnon, B.
Mezzano, S.
Schena, F.
Tomino, Y.
Walker, P.
Wang, H.
Weening, J.
Yoshikawa, N.
Zeng, Cai-Hong
Shi, Sufang
Nogi, C.
Suzuki, H.
Koike, K.
Hirano, K.
Yokoo, T.
Hanai, M.
Fukami, K.
Takahashi, K.
Yuzawa, Y.
Niwa, M.
Yasuda, Y.
Maruyama, S.
Ichikawa, D.
Suzuki, T.
Shirai, S.
Fukuda, A.
Fujimoto, S.
Trimarchi, H.
Barbour, Sean J.
Coppo, Rosanna
Zhang, Hong
Liu, Zhi-Hong
Suzuki, Yusuke
Matsuzaki, Keiichi
Katafuchi, Ritsuko
Er, Lee
Espino-Hernandez, Gabriela
Kim, S. Joseph
Reich, Heather N.
Feehally, John
Cattran, Daniel C.
Russo, M. L.
Troyanov, S.
Cook, H. T.
Roberts, I.
Tesar, V.
Maixnerova, D.
Lundberg, S.
Gesualdo, L.
Emma, F.
Fuiano, L.
Beltrame, G.
Rollino, C.
Amore, A.
Camilla, R.
Peruzzi, L.
Praga, M.
Feriozzi, S.
Polci, R.
Segoloni, G.
Colla, L.
Pani, A.
Piras, D.
Angioi, A.
Cancarini, G.
Ravera, S.
Durlik, M.
Moggia, E.
Ballarin, J.
Di Giulio, S.
Pugliese, F.
Serriello, I.
Caliskan, Y.
Sever, M.
Kilicaslan, I.
Locatelli, F.
Del Vecchio, L.
Wetzels, J. F. M.
Peters, H.
Berg, U.
Carvalho, F.
da Costa Ferreira, A. C.
Maggio, M.
Wiecek, A.
Ots-Rosenberg, M.
Magistroni, R.
Topaloglu, R.
Bilginer, Y.
D'Amico, M.
Stangou, M.
Giacchino, F.
Goumenos, D.
Kalliakmani, P.
Gerolymos, M.
Galesic, K.
Geddes, C.
Siamopoulos, K.
Balafa, O.
Galliani, M.
Stratta, P.
Quaglia, M.
Bergia, R.
Cravero, R.
Salvadori, M.
Cirami, L.
Fellström, Bengt
Smerud, Hilde Kloster
Ferrario, F.
Stellato, T.
Egido, J.
Martin, C.
Floege, J.
Eitner, F.
Lupo, A.
Bernich, P.
Mene, R.
Morosetti, M.
van Kooten, C.
Rabelink, T.
Reinders, M. E. J.
Boria Grinyo, J. M.
Cusinato, S.
Benozzi, L.
Savoldi, S.
Licata, C.
Mizerska-Wasiak, M.
Martina, G.
Messuerotti, A.
Dal Canton, A.
Esposito, C.
Migotto, C.
Triolo, G.
Mariano, F.
Pozzi, C.
Boero, R.
Bellur, S.
Mazzucco, G.
Giannakakis, C.
Honsova, E.
Sundelin, B.
Di Palma, A. M.
Gutierrez, E.
Asunis, A. M.
Barratt, J.
Tardanico, R.
Perkowska-Ptasinska, A.
Arce Terroba, J.
Fortunato, M.
Pantzaki, A.
Ozluk, Y.
Steenbergen, E.
Soderberg, M.
Riispere, Z.
Furci, L.
Orhan, D.
Kipgen, D.
Casartelli, D.
Ljubanovic, D. Galesic
Gakiopoulou, H.
Bertoni, E.
Cannata Ortiz, P.
Karkoszka, H.
Groene, H. J.
Stoppacciaro, A.
Bajema, I.
Bruijn, J.
Fulladosa Oliveras, X.
Maldyk, J.
Loachim, E.
Bavbek, N.
Cook, T.
Alpers, C.
Berthoux, F.
Bonsib, S.
D'Agati, V
D'Amico, G.
Emancipator, S.
Emmal, F.
Fervenza, F.
Florquin, S.
Fogo, A.
Groene, H.
Haas, M.
Hill, P.
Hogg, R.
Hsu, S.
Hunley, T.
Hladunewich, M.
Jennette, C.
Joh, K.
Julian, B.
Kawamura, T.
Lai, F.
Leung, C.
Li, L.
Li, P.
Liu, Z.
Massat, A.
Mackinnon, B.
Mezzano, S.
Schena, F.
Tomino, Y.
Walker, P.
Wang, H.
Weening, J.
Yoshikawa, N.
Zeng, Cai-Hong
Shi, Sufang
Nogi, C.
Suzuki, H.
Koike, K.
Hirano, K.
Yokoo, T.
Hanai, M.
Fukami, K.
Takahashi, K.
Yuzawa, Y.
Niwa, M.
Yasuda, Y.
Maruyama, S.
Ichikawa, D.
Suzuki, T.
Shirai, S.
Fukuda, A.
Fujimoto, S.
Trimarchi, H.
Publication Year :
2019

Abstract

Importance Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the world, there is no validated tool to predict disease progression. This limits patient-specific risk stratification and treatment decisions, clinical trial recruitment, and biomarker validation. Objective To derive and externally validate a prediction model for disease progression in IgAN that can be applied at the time of kidney biopsy in multiple ethnic groups worldwide. Design, Setting, and Participants We derived and externally validated a prediction model using clinical and histologic risk factors that are readily available in clinical practice. Large, multi-ethnic cohorts of adults with biopsy-proven IgAN were included from Europe, North America, China, and Japan. Main Outcomes and Measures Cox proportional hazards models were used to analyze the risk of a 50% decline in estimated glomerular filtration rate (eGFR) or end-stage kidney disease, and were evaluated using the R2D measure, Akaike information criterion (AIC), C statistic, continuous net reclassification improvement (NRI), integrated discrimination improvement (IDI), and calibration plots. Results The study included 3927 patients; mean age, 35.4 (interquartile range, 28.0-45.4) years; and 2173 (55.3%) were men. The following prediction models were created in a derivation cohort of 2781 patients: a clinical model that included eGFR, blood pressure, and proteinuria at biopsy; and 2 full models that also contained the MEST histologic score, age, medication use, and either racial/ethnic characteristics (white, Japanese, or Chinese) or no racial/ethnic characteristics, to allow application in other ethnic groups. Compared with the clinical model, the full models with and without race/ethnicity had better R2D (26.3% and 25.3%, respectively, vs 20.3%) and AIC (6338 and 6379, respectively, vs 6485), significant increases in C statistic from 0.78 to 0.82 and 0.81, respectively (ΔC, 0.04; 95% CI, 0.03-0.04 and ΔC, 0.03

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1235229975
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1001.jamainternmed.2019.0600